DelSiTech Ltd nhasi yazivisa chibvumirano cherezinesi chakasarudzika chine chekuita nekugadzirwa kweanodzorwa-kuburitsa madonhwe emeso edexamethasone achishandisa tekinoroji yeDelSiTech™ Silica Matrix.
Dexamethasone mushonga wecorticosteroid unogara uchishandiswa muophthalmology kurapa kuzvimba kwemaziso kunokonzerwa nezvikonzero zvakasiyana-siyana senge allergy uye kukuvara kweziso. Inowanzoshandiswa kutevera kuvhiyiwa kweziso senge cataract maitiro ekukurumidza kupora uye kuderedza marwadzo muziso. Parizvino, madonhwe emeso edexamethasone anoshandiswa 4-10 nguva pazuva kazhinji zvichiita kuti kuve nekusateerera kwekurapa uye kuderedzwa kwekushanda, zvichinyanya kuita kurapa kwehutano uye kusunungurwa kunotarisirwa nevarwere. Kudzorwa kuburitswa kwedexamethasone ziso madonhwe, zvichibva paDelSiTech ™ Silica Matrix tekinoroji, inoshandura ziso rekudonhedza chigadzirwa chinoshandiswa sedonhwe rimwe chete, kamwe pazuva pasi pechivharo cheziso chinochengetedza kurapwa kwemishonga muziso kwezuva rose, kubvisa kudiwa kwekudzokorora maapplication.
Janos Vaczi, Managing Director weOptifye Therapeutics akati: “KuOptifye tinogovana nzwisiso yekuti hutsva hutsva hunodiwa nekuchimbidza pakukanganisika kwechikamu cheziso chepamberi, icho chinowanzoregeredzwa. Isu tinoona nguva nyowani yekurapa kwekudonha kwemaziso nekuda kwekusimudzira kwakakosha kwetekinoroji, iyo inonakidza inoshanda kune mazhinji mukushandisa zvinosanganisirwa muophthalmology. Tinotarisira kuswedera pedyo nenguva yekusashanda uye nguva dzose dosing, tichiwedzera zororo kuvarwere. "
Dr. Lasse Leino, Mutungamiriri Mukuru weDelSiTech akati: "DelSiTech™ Silica Matrix tekinoroji inogonesa kukurumidza kukurumidza kusunungurwa kwemishonga yemishonga nenzira yemadonhwe emeso, kuderedza dosing kusvika kamwe chete zuva nezuva kana zvishoma. Isu tinofara kushanda pamwe nechikwata cheOptifye kuunza mhinduro dzekudonhedza ziso kune varwere. Kuenderera mberi kwekusimbisa matekinoroji edu kunotikurudzira iye zvino kupfuura nakare kose kusunda kupfuura budiriro uye mukushambadzira. Isu tinokoshesa vatinoshanda navo vakaita saOptifiye, kwete chete nehunyanzvi hwekutungamira muophthalmology, asi nebasa ravo mukufambira mberi kweDelSiTech kusvika pakuva kambani yekutengeserana yemishonga ine huvepo hwakakosha muchikamu chemaziso. "
ZVOKUBVA MUNYAYA INO:
- Controlled release of dexamethasone eye drops, based on DelSiTech™ Silica Matrix technology, is a revolutionary eye drop product that is applied as a single drop, once daily under the eye lid which maintains therapeutic drug concentration in the eye for the entirety of the day, removing the need for repeat applications.
- We value partners such as Optifye, not only for their guiding expertise in ophthalmology, but for their role in DelSiTech’s ongoing advancement towards becoming a commercial pharmaceutical company with an important presence in the ophthalmic sector.
- We foresee a new era for eye drop treatments owing to significant technological advancements, which excitingly are applicable to most in use active ingredients in ophthalmology.
